- Home
- AVTX vs BLZR Comparison
AVTX vs BLZR Comparison
Compare AVTX & BLZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$17.76
Company Overview
Basic Information| Metric | AVTX | BLZR |
|---|---|---|
| Founded | 2011 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 328.4M | 344.8M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AVTX | BLZR |
|---|---|---|
| Price | $17.76 | $10.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $40.57 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 50.7K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 72.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,813,137.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2312.27 | N/A |
| 52 Week Low | $4.73 | $10.00 |
| 52 Week High | $24.27 | $10.15 |
Technical Indicators
Market Signals| Indicator | AVTX | BLZR |
|---|---|---|
| Relative Strength Index (RSI) | 64.69 | 52.13 |
| Support Level | $13.13 | $10.01 |
| Resistance Level | $19.06 | $10.12 |
| Average True Range (ATR) | 1.06 | 0.01 |
| MACD | 0.55 | -0.00 |
| Stochastic Oscillator | 92.22 | 33.33 |
Price Performance
Historical Comparison AVTX
BLZR
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
About BLZR Trailblazer Acquisition Corp. Class A Ordinary Shares
Trailblazer Acquisition Corp is a blank check company.